Innolake Biopharm
Hangzhou
About Innolake Biopharm
Innolake Biopharm clinical-stage biotech company with a focus on oncology and autoimmune disease areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $60.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: innolakebio.com
- Phone: +86-21-3886 3300
Industries & Categories
Biotechnology, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/innolake-biopharm-12318 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.